200 related articles for article (PubMed ID: 20639381)
1. Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature.
Benedetti L; Briani C; Franciotta D; Fazio R; Paolasso I; Comi C; Luigetti M; Sabatelli M; Giannini F; Mancardi GL; Schenone A; Nobile-Orazio E; Cocito D
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):306-8. PubMed ID: 20639381
[TBL] [Abstract][Full Text] [Related]
2. Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy.
D'Amico A; Catteruccia M; De Benedetti F; Vivarelli M; Colucci M; Cascioli S; Bertini E
Eur J Paediatr Neurol; 2012 May; 16(3):301-3. PubMed ID: 21903431
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
[TBL] [Abstract][Full Text] [Related]
4. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
Tracy JA; Dyck PJ
Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
[TBL] [Abstract][Full Text] [Related]
5. Rituximab in chronic inflammatory demyelinating polyradiculoneuropathy with associated diseases.
Roux T; Debs R; Maisonobe T; Lenglet T; Delorme C; Louapre C; Leblond V; Viala K
J Peripher Nerv Syst; 2018 Dec; 23(4):235-240. PubMed ID: 30203907
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.
Bright RJ; Wilkinson J; Coventry BJ
BMC Neurol; 2014 Feb; 14():26. PubMed ID: 24507546
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in refractory chronic inflammatory demyelinating polyneuropathy.
Muley SA; Jacobsen B; Parry G; Usman U; Ortega E; Walk D; Allen J; Pasnoor M; Varon M; Dimachkie MM
Muscle Nerve; 2020 May; 61(5):575-579. PubMed ID: 31922613
[TBL] [Abstract][Full Text] [Related]
8. Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis.
Sadnicka A; Reilly MM; Mummery C; Brandner S; Hirsch N; Lunn MP
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):230-2. PubMed ID: 20462915
[TBL] [Abstract][Full Text] [Related]
9. [Chronic inflammatory demyelinating polyradiculoneuropathy].
Franques J; Azulay JP; Pouget J; Attarian S
Rev Med Interne; 2010 Jun; 31(6):411-6. PubMed ID: 20395023
[TBL] [Abstract][Full Text] [Related]
10. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
Vina ER; Fang AJ; Wallace DJ; Weisman MH
Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
[TBL] [Abstract][Full Text] [Related]
12. Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura.
Benedetti L; Franciotta D; Beronio A; Cadenotti L; Gobbi M; Mancardi GL; Schenone A; Tartaglione A
Muscle Nerve; 2008 Aug; 38(2):1076-7. PubMed ID: 18642360
[No Abstract] [Full Text] [Related]
13. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
Gorson KC; Natarajan N; Ropper AH; Weinstein R
Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
[TBL] [Abstract][Full Text] [Related]
14. Rituximab therapy in chronic inflammatory demyelinating polyradiculoneuropathy with anti-SGPG IgM antibody.
Gono T; Matsuda M; Shimojima Y; Ishii W; Yamamoto K; Morita H; Hashimoto T; Susuki K; Yuki N; Ikeda S
J Clin Neurosci; 2006 Jul; 13(6):683-7. PubMed ID: 16814550
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of rituximab treatment in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.
Hu J; Sun C; Lu J; Zhao C; Lin J
J Neurol; 2022 Mar; 269(3):1250-1263. PubMed ID: 34120208
[TBL] [Abstract][Full Text] [Related]
16. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Cocito D; Paolasso I; Antonini G; Benedetti L; Briani C; Comi C; Fazio R; Jann S; Matà S; Mazzeo A; Sabatelli M; Nobile-Orazio E;
Eur J Neurol; 2010 Feb; 17(2):289-94. PubMed ID: 19863650
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment.
Sanz PG; García Méndez CV; Cueto AL; Silva VB; Walther JC; Diez RA; Martins S; Giannaula RJ
Rheumatol Int; 2012 Dec; 32(12):4061-3. PubMed ID: 21922339
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.
Münch C; Anagnostou P; Meyer R; Haas J
J Neurol Sci; 2007 May; 256(1-2):100-2. PubMed ID: 17382963
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy.
Markvardsen LH; Debost JC; Harbo T; Sindrup SH; Andersen H; Christiansen I; Otto M; Olsen NK; Lassen LL; Jakobsen J;
Eur J Neurol; 2013 May; 20(5):836-42. PubMed ID: 23294032
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
Eftimov F; van Schaik I
Curr Opin Neurol; 2013 Oct; 26(5):496-502. PubMed ID: 23852276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]